🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Use of Continuous Glucose Monitors in Children and Adolescents With Obesity

RecruitingNAAges 10 Years - 21 YearsAllUniversity of California, Los Angeles
NCT06254768 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

To study if continuous glucose monitors are feasible for use in children and adolescents with obesity.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 10-21 years BMI \>95th percentile Exclusion Criteria: * Previous diagnosis of Prader Willi Syndrome or hypothalamic obesity * Intellectual disability * Previous or planned bariatric surgery * Hemoglobin A1c \>6.5 % * Current use of medication that impacts weight
💊

What it tests

  • Continuous glucose monitor
📍

Where

1 site
Pediatric Endocrinology Division, University of California
Los Angeles, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy